Medigen Vaccine Biologics Corp.
Climate Impact & Sustainability Data (2023)
Reporting Period: 2023
Environmental Metrics
Total Carbon Emissions:5360.04 tCO2e/year (Scope 1: 1538.46 tons in 2023; Scope 2: 3821.58 tons in 2023)
Scope 1 Emissions:1538.46 tCO2e/year
Scope 2 Emissions:3821.58 tCO2e/year
Water Consumption:43.61 Million liters/year
Waste Generated:11.05 tons/year
ESG Focus Areas
- Environmental Protection
- Employee Well-being
- Corporate Governance
Environmental Achievements
- Reduced water consumption from 62.93 Million liters in 2022 to 43.61 Million liters in 2023
- Reduced total waste from 10.01 tons in 2022 to 11.05 tons in 2023 (Note: slight increase, needs further investigation)
Social Achievements
- Implemented various employee welfare measures including year-end bonuses, bonuses, employee education training, and group insurance.
- Maintained a harmonious labor-management relationship with no labor disputes.
Governance Achievements
- Established a chief governance officer to handle corporate governance matters.
- Implemented a robust internal control system, regularly audited for compliance.
Climate Goals & Targets
Long-term Goals:
- Conduct a greenhouse gas inventory and verify it by a third party; reduce carbon emissions by 1%-2% year by year; continue improving the equipment operation process and enhancing energy efficiency.
Medium-term Goals:
- Conduct greenhouse gas inventory; reduce carbon emissions year by year; continuously improve equipment operation processes.
Short-term Goals:
- Collect and survey internal carbon emission data; propose plans to improve equipment operation processes and enhance energy efficiency.
Environmental Challenges
- Decreasing birth rate in Taiwan affecting the size of consumer groups for infant vaccines.
- Relatively smaller scale of Taiwanese biotech companies compared to international pharmaceutical companies.
Mitigation Strategies
- Pursuing a higher-price product strategy for differentiation and expanding into the ASEAN market.
- Strengthening competitive advantage through international collaborations (WHO Solidarity Trial Vaccine, CEPI, WHO C-TAP).
Supply Chain Management
Responsible Procurement
- Evaluates suppliers’ legality and ethical records; requires compliance with GMP, GDP, or other industry standards.
Climate-Related Risks & Opportunities
Physical Risks
- Abnormal weather conditions, natural disasters (typhoons, floods, droughts)
Transition Risks
- Carbon reduction policies and regulations
- Control of corporate carbon footprint
- Suppliers' compliance with relevant policies and regulations
Reporting Standards
Frameworks Used: GRI
Certifications: PIC/S GMP
Sustainable Products & Innovation
- EV71 vaccine
- Quadrivalent influenza vaccine
- COVID-19 vaccine